NRIX
Nurix Therapeutics Inc
Price:
12.67
USD
Volume:
4,404,954
United States | Biotechnology
NRIX Gross Margin
As of 2025-07-11, the Gross Margin of Nurix Therapeutics Inc (NRIX) is 7775.2%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
NRIX Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2024-11-30 | 7775.2% |
| 2023-11-30 | - |
| 2022-11-30 | - |
| 2021-11-30 | - |
| 2020-11-30 | - |
| 2019-11-30 | - |
| 2018-11-30 | - |
| - | |
| - | |
| - |
NRIX Gross Margin - Peers Comparison